A Phase 3 Multicenter Randomized Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethsone in Subjects with t(11;14) Positive Relapsed or Refractory Multiple Myeloma

March 13, 2019
https://clinicaltrials.gov/ct2/show/NCT03539744
Cancer - Myeloma
Principal Investigator: Philip Kuriakose, MD
myeloma, venetoclax, pomalidomide
Accepting Participants